The FDA is issuing a proposed rule to amend the final monograph (FM) for OTC dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff. The agency is issuing this proposed rule after considering information submitted in a citizen petition. In 1993, FDA received a petition to amend the FM for OTC dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 9% coal tar solution and 1.5% menthol in a shampoo drug product to relieve scalp itching associated with dandruff. To submit electronic comments by March 9, 2006, visit http://www.regulations.gov/.
Q&A: Retail, Independent Pharmacies Continue to Call for Improved Reimbursement Practices
June 30th 2025Rick Gates, chief pharmacy officer at Walgreens and chairman of the National Association of Chain Drug Stores, discussed the current status of retail pharmacies and the way they are reimbursed.